Skip to main content

Table 2 Surgical outcomes and prognosis of patients undergoing robotic thrombectomy for high inferior vena cava cancer thrombus a

From: Step-by-step and orderly lowering of the height of inferior vena cava tumor thrombus is the key to robot-assisted thrombectomy for Mayo III/IV tumor thrombus

Characteristic

No CPB

CPB

Total

Surgical outcomes

 Height of the cancer thrombus, n (%)

  Limited in IVC

11 (100.0)

0 (0.0)

11 (61.1)

  Into the right atrium

0 (0.0)

7 (100.0)

7 (38.9)

 Transfer to laparotomy, n (%)

  Yes

2 (18.2)

0 (0.0)

2 (11.1)

  No

9 (81.8)

7 (100.0)

16 (88.9)

 Times of cancer thrombus drops, n (%)

  1

2 (18.2)

0 (0.0)

2 (11.1)

  2

9 (81.8)

6 (85.7)

15 (83.3)

  3

0 (0.0)

1 (14.3)

1 (5.6)

Liver/IVC dissociation and vascular suspension time (min), median (IQR)

20 (14-26)

29 (20-33)

22 (14-32)

Blood loss during Liver /IVC dissociation and blood vessel suspension (ml), median (IQR)

400 (200-750)

600 (250-1200)

530 (230-1000)

Operative time (min), median (IQR)

355.0 (305.0-465.0)

540.0 (525.0-593.3)

465.0 (338.0-540.0)

Intraoperative blood loss (ml), median (IQR)

1000.0 (950.0-2500.0)

2750.0 (1375.0-5250.0)

1500.0 (1000.0-3500.0)

Intraoperative transfusion (ml), median (IQR)

1200.0 (600.0-1230.0)

3320.0 (1300.0-4215.0)

1200.0 (990.0-3240.0)

 Postoperative recovery and prognosis

  Postoperative ICU transition days (d), mean (IQR)

2 (1-4)

3 (1-6)

3 (2-5)

  Postoperative drainage time (d), mean (IQR)

4 (3-7)

5 (4-7)

5 (3-7)

  Postoperative hospital stay (d), mean (IQR)

8.0 (6.0-11.5)

11.5 (9.3-14.4)

10.0 (7.0-13.0)

 Perioperative complications d, n (%)

  ≤IIIa

11 (100.0)

7 (100.0)

18 (100.0)

  ≥IIIb

0 (0.0)

0 (0.0)

0 (0.0)

90-day mortality, (%)

0

0

0

 Follow-up (12 Month), n (%)

  Alive

5 (45.5)

3 (42.9)

8 (44.4)

  Dead

1 (9.0)

1 (14.3)

2 (11.2)

  Loss to follow-up

5 (45.5)

3 (42.9)

8 (44.4)

 Pathologic types, n (%)

  ccRCC

9 (81.8)

6 (85.7)

15 (83.3)

  UC

1 (9.1)

0 (0.0)

1 (5.6)

  PRCC

1 (9.1)

1 (14.3)

2 (11.1)

 Fuhrman stage, n (%)

  I

0 (0.0)

0 (0.0)

0 (0.0)

  II

5 (45.4)

1 (14.3)

6 (33.4)

  III

4 (36.4)

4 (57.1)

8 (44.4)

  IV

2 (18.2)

2 (28.6)

4 (22.2)

  1. Abbreviations: CPB Cardiopulmonary bypass, IVC inferior vena cava, IQR interquartile range, Hb hemoglobin, ALB albumin, AST Aspartate Aminotransferase, Cr Creatinine, BUN Blood Urea Nitrogen, ccRCC clear cell renal cell carcinoma, UC Urothelial Carcinoma, PRCC papillary renal cell carcinoma
  2. Note:
  3. a The height of inferior vena cava cancer thrombus higher than the lower margin of the SPH is called high inferior vena cava cancer thrombus
  4. d According to the Clavien-Dindo classification of surgical complications